NCT03236324View on ClinicalTrials.gov

Transversalis Fascia Plane Blocks for Analgesia Post-cesarean Delivery

PHASE2CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

September 22, 2017

Primary Completion Date

October 13, 2022

Study Completion Date

December 11, 2022

Conditions
Cesarean Delivery
Interventions
DEVICE

ultrasound-guided nerve block

Transversalis fascia plane (TFP) block, ultrasound-guided

DRUG

Saline

20 mL 0.9% saline administered on each side as bilateral TFP blocks

DRUG

Bupivacaine-epinephrine

20 mL bupivacaine 0.25% with epinephrine 2.5 mcg/mL to a maximum of 2.5mg/kg administered on each side as bilateral TFP blocks

Trial Locations (1)

T3M 1M4

South Health Campus, Calgary

All Listed Sponsors
lead

University of Calgary

OTHER

NCT03236324 - Transversalis Fascia Plane Blocks for Analgesia Post-cesarean Delivery | Biotech Hunter | Biotech Hunter